0000046250FALSE00000462502024-07-312024-07-31

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM 8-K
 
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) July 31, 2024
  
Hawkins, Inc.
(Exact name of registrant as specified in its charter)
 
Minnesota 0-7647 41-0771293
(State of Incorporation) (Commission File Number) (IRS Employer Identification No.)
2381 Rosegate,Roseville,Minnesota55113
(Address of Principal Executive Offices)(Zip Code)

Registrant’s Telephone Number, Including Area Code (612) 331-6910
  
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $.01 per share
HWKN
Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act (17 CFR 230.405) or Rule 12b-2 of the Exchange Act (17 CFR 240.12b 2).

Emerging growth company ¨
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨



Item 2.02. Results of Operations and Financial Condition.
On July 31, 2024, Hawkins, Inc. issued a press release announcing financial results for its fiscal 2025 first quarter ended June 30, 2024. A copy of the press release issued by the Registrant is furnished herewith as Exhibit 99.1 hereto and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.
(d)Exhibits.
Exhibit No.  Description  Method of Filing
  
Press Release, dated July 31, 2024, announcing financial results of Hawkins, Inc. for its fiscal 2025 first quarter ended June 30, 2024.
  Filed Electronically
104 Cover Page Interactive Data File (embedded within the inline XBRL document)Filed Electronically



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 HAWKINS, INC.
Date: July 31, 2024
 By: /s/ Jeffrey P. Oldenkamp
  Jeffrey P. Oldenkamp
  Executive Vice President and Chief Financial Officer



Exhibit 99.1
Hawkins, Inc. Reports
First Quarter Fiscal 2025 Results

Roseville, Minn., July 31, 2024 – Hawkins, Inc. (Nasdaq: HWKN) today announced results for the three months ended June 30, 2024, its first quarter of fiscal 2025.

First Quarter Fiscal Year 2025 Highlights:

•Record quarterly results for revenue, gross profit, operating income, net income, diluted earnings per share (“EPS”) and adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (“adjusted EBITDA”), a non-GAAP measure.
•Revenue growth of 2% driven by Water Treatment segment growth of 25% over the same period of the prior year.
•Gross profit increase of 24% over the same period of the prior year, with all three segments having double-digit growth.
•Diluted EPS increase of $0.26, or 23%, to $1.38 per share.
•Adjusted EBITDA, a non-GAAP measure, of $50.9 million, a 25% increase over the same period of the prior year. Trailing 12-month adjusted EBITDA exceeds $153 million.
•As previously announced, closed on two acquisitions in the first quarter, further expanding our geographic reach within our Water Treatment segment.
•For the fourth year in a row, Hawkins was certified as a Great Place to Work.

Executive Commentary – Patrick H. Hawkins, Chief Executive Officer and President:

“We are extremely pleased with our strong first quarter results with Water Treatment becoming our largest reporting segment, and our profitability continuing to grow by over 20% as we again experienced revenue and volume growth," said Patrick Hawkins, Chief Executive Officer and President. "Our record revenue of $256 million was driven by our acquired businesses in our Water Treatment segment. Revenue was down in our Industrial segment due primarily to reduced selling prices driven by lower commodity costs, with volumes relatively flat year over year. Revenue in our Health and Nutrition segment was also down slightly due to product mix changes. Gross profit increased double digits in all three of our segments due to the product mix and our continued focus on pricing discipline. Our continuing strategy of investing in higher margin business has helped drive the growth results we have experienced over the last five years. I am extremely proud of the entire Hawkins team, and the commitment of each and every employee has contributed to the success of our company.”

Mr. Hawkins, continued, “We closed two acquisitions in our Water Treatment segment in the first quarter, and have now completed six acquisitions in the last 12 months, expanding our geographic reach in this segment. We are also happy that we continue to realize synergies with each deal. Our balance sheet continues to be strong, and our leverage ratio at the end of the first quarter was 0.84x. Looking to the future, we expect all three segments to continue to grow profitability and we will continue to deliver on our strategy of investing in our higher margin businesses, while servicing the needs of our customers to the highest level possible.”

First Quarter Financial Highlights:

NET INCOME
For the first quarter of fiscal 2025, the Company reported net income of $28.9 million, or $1.38 per diluted share, compared to net income for the first quarter of fiscal 2024 of $23.4 million, or $1.12 per diluted share.
REVENUE
Sales were $255.9 million for the first quarter of fiscal 2025, an increase of $4.8 million, or 2%, from sales of $251.1 million in the same period a year ago. Increased sales in our Water Treatment segment more than offset decreased sales in our Industrial and Health and Nutrition segments. Water Treatment segment sales increased $23.5 million, or 25%, to $117.2 million for the current quarter, from $93.7 million in the same period a year ago. Water Treatment sales increased as a result of added sales from our acquired businesses. Industrial segment sales decreased $17.7 million, or 15%, to $103.2 million for the current quarter, from $120.9 million in the same period a year ago. The decrease in sales was primarily driven by lower selling prices on certain products driven by lower raw material costs and volume pressure. Health and Nutrition segment sales decreased $1.1 million, or 3.0%, to $35.5 million for the current quarter, from $36.6 million in the same period a year ago. Health and Nutrition sales decreased as a result of lower sales of our manufactured products, largely offset by increased sales of our specialty distributed products.


GROSS PROFIT
Gross profit increased $12.7 million, or 24%, to $64.7 million, or 25% of sales, for the current quarter, from $52.0 million, or 21% of sales, in the same period a year ago. During the current quarter, the LIFO reserve increased, and gross profit decreased, by $0.4 million due primarily to an increase in our forecasted year-end quantities. In the same quarter a year ago, the LIFO reserve decreased, and gross profit increased, by $0.2 million. Gross profit for the Water Treatment segment increased $8.6 million, or 33%, to $35.0 million, or 30% of sales, for the current quarter, from $26.4 million, or 28% of sales, in the same period a year ago. Water Treatment segment gross profit increased primarily as a result of increased sales from our acquired businesses. Gross profit for the Industrial segment increased $2.6 million, or 13%, to $21.9 million, or 21% of sales, for the current quarter, from $19.3 million, or 16% of sales, in the same period a year ago. Industrial segment gross profit increased as a result of improved unit margins on certain products. Gross profit for our Health and Nutrition segment increased $1.5 million, or 24%, to $7.8 million, or 22% of sales, for the current quarter, from $6.3 million, or 17% of sales, in the same period a year ago. Health and Nutrition segment gross profit increased as a result of improved margins on certain products.
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES
Selling, general and administrative expenses increased $5.4 million, or 28%, to $24.9 million, or 10% of sales, for the current quarter, from $19.5 million, or 8% of sales, in the same period a year ago. Expenses increased primarily due to added costs from the acquired businesses in our Water Treatment segment and increased variable pay.
ADJUSTED EBITDA
Adjusted EBITDA, a non-GAAP financial measure, is an important performance indicator and a key compliance measure under the terms of our credit agreement. An explanation of the computation of adjusted EBITDA is presented below. Adjusted EBITDA for the three months ended June 30, 2024 was $50.9 million, an increase of $10.0 million, or 25%, from $40.9 million in the same period a year ago.
INCOME TAXES
Our effective income tax rate was 25% for the current quarter and 26% for the same period a year ago. The effective tax rate in the first quarter of both years was impacted by favorable tax provision adjustments recorded. The effective tax rate is impacted by projected levels of annual taxable income, permanent items, and state taxes. Our effective tax rate for the full year is currently expected to be approximately 26-27%.
BALANCE SHEET
During the first quarter, our working capital was $24 million higher than the end of fiscal 2024 due primarily to increased customer receivable balances, increased inventory and lower liabilities due to the payment of certain year-end accruals in the first quarter. During the quarter, net borrowings of $35.0 million and $17.6 million of operating cash flow was used to fund $25.4 million of acquisition spending for the acquisitions of Intercoastal Trading, Inc. and Wofford Water Service, Inc., capital spending of $10.6 million, stock repurchases of $9.1 million and dividend payments of $3.4 million. Our total debt outstanding at the end of the first quarter was $134.0 million and our leverage ratio was 0.84x our trailing twelve-month proforma adjusted EBITDA, as compared to 0.66x of trailing twelve-month adjusted EBITDA at the end of fiscal 2024.

About Hawkins, Inc.

Hawkins, Inc. was founded in 1938 and is a leading specialty chemical and ingredients company that formulates, distributes, blends, and manufactures products for its Industrial, Water Treatment, and Health & Nutrition customers. Headquartered in Roseville, Minnesota, the Company has 60 facilities in 27 states and creates value for its customers through superb customer service and support, quality products and personalized applications. Hawkins, Inc. generated $919 million of revenue in fiscal 2024 and has approximately 950 employees. For more information, including registering to receive email alerts, please visit www.hawkinsinc.com/investors.

Reconciliation of Non-GAAP Financial Measures
We report our consolidated financial results in accordance with U.S. generally accepted accounting principles (GAAP). To assist investors in understanding our financial performance between periods, we have provided certain financial measures not computed according to GAAP, including adjusted EBITDA. This non-GAAP financial measure is not meant to be considered in isolation or as a substitute for comparable GAAP measures. The method we use to produce non-GAAP results is not computed according to GAAP and may differ from the methods used by other companies.
Management uses this non-GAAP financial measure internally to understand, manage and evaluate our business and to make operating decisions. Management believes that this non-GAAP financial measure reflects an additional way of viewing aspects of our operations that, when viewed with our GAAP results, provides a more complete understanding of the factors and trends affecting our financial condition and results of operations.


We define adjusted EBITDA as GAAP net income adjusted for the impact of the following: net interest expense resulting from our net borrowing position; income tax expense; non-cash expenses including amortization of intangibles, depreciation and charges for the employee stock purchase plan and restricted stock grants; and non-recurring items of income or expense, if applicable.

Adjusted EBITDAThree Months Ended
(In thousands)June 30, 2024July 2, 2023
Net Income (GAAP)$28,879 $23,430 
Interest expense, net1,263 1,148 
Income tax expense9,808 8,246 
Amortization of intangibles2,802 1,670 
Depreciation expense6,527 5,437 
Non-cash compensation expense1,467 959 
Non-recurring acquisition expenses 188 — 
Adjusted EBITDA$50,934 $40,890 




 
HAWKINS, INC.
CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)
(In thousands, except share and per-share data)
Three Months Ended
June 30, 2024July 02, 2023
Sales$255,879 $251,120 
Cost of sales(191,224)(199,129)
Gross profit64,655 51,991 
Selling, general and administrative expenses(24,864)(19,504)
Operating income39,791 32,487 
Interest expense, net(1,263)(1,148)
Other income159 337 
Income before income taxes38,687 31,676 
Income tax expense(9,808)(8,246)
Net income$28,879 $23,430 
Weighted average number of shares outstanding - basic20,816,479 20,907,724 
Weighted average number of shares outstanding - diluted20,914,085 21,012,788 
Basic earnings per share$1.39 $1.12 
Diluted earnings per share$1.38 $1.12 
Cash dividends declared per common share$0.16 $0.15 
 





HAWKINS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)
(In thousands, except share data)
June 30,
2024		March 31,
2024
ASSETS
CURRENT ASSETS:
Cash and cash equivalents$8,887 $7,153 
Trade accounts receivables, net126,398 114,477 
Inventories81,199 74,600 
Prepaid expenses and other current assets5,503 6,596 
Total current assets221,987 202,826 
PROPERTY, PLANT, AND EQUIPMENT:396,244 386,648 
Less accumulated depreciation182,604 177,774 
Net property, plant, and equipment213,640 208,874 
OTHER ASSETS:
Right-of-use assets12,157 11,713 
Goodwill114,046 103,399 
Intangible assets, net of accumulated amortization124,563 116,626 
Deferred compensation plan asset11,365 9,584 
Other4,980 4,912 
Total other assets267,111 246,234 
Total assets$702,738 $657,934 
LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES:
Accounts payable — trade$47,795 $56,387 
Accrued payroll and employee benefits12,501 19,532 
Income tax payable11,751 1,943 
Current portion of long-term debt9,913 9,913 
Environmental remediation7,700 7,700 
Other current liabilities8,332 7,832 
Total current liabilities97,992 103,307 
LONG-TERM DEBT, LESS CURRENT PORTION123,840 88,818 
LONG-TERM LEASE LIABILITY9,816 9,530 
PENSION WITHDRAWAL LIABILITY3,443 3,538 
DEFERRED INCOME TAXES22,367 22,406 
DEFERRED COMPENSATION LIABILITY12,244 11,764 
EARNOUT LIABILITY11,577 11,235 
OTHER LONG-TERM LIABILITIES241 1,310 
Total liabilities281,520 251,908 
COMMITMENTS AND CONTINGENCIES
SHAREHOLDERS’ EQUITY:
Common stock; authorized: 60,000,000 shares of $0.01 par value; 20,734,331 and 20,790,261 shares issued and outstanding as of June 30, 2024 and March 31, 2024, respectively
207 208 
Additional paid-in capital27,932 38,154 
Retained earnings390,070 364,549 
Accumulated other comprehensive income3,009 3,115 
Total shareholders’ equity421,218 406,026 
Total liabilities and shareholders’ equity$702,738 $657,934 



HAWKINS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
(In thousands)
 
 Three Months Ended
 June 30,
2024		July 2,
2023
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income$28,879 $23,430 
Reconciliation to cash flows:
Depreciation and amortization9,329 7,107 
Change in fair value of earnout liability342 — 
Operating leases782 534 
Gain on deferred compensation assets(159)(337)
Stock compensation expense1,467 959 
Other(65)26 
Changes in operating accounts providing (using) cash:
Trade receivables(10,576)(9,055)
Inventories(6,037)11,839 
Accounts payable(7,300)(537)
Accrued liabilities(8,949)(9,075)
Lease liabilities(834)(580)
Income taxes9,808 8,255 
Other899 2,300 
Net cash provided by operating activities17,586 34,866 
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property, plant, and equipment(10,649)(7,873)
Acquisitions(25,400)— 
Other 245 44 
Net cash used in investing activities(35,804)(7,829)
CASH FLOWS FROM FINANCING ACTIVITIES:
Cash dividends declared and paid(3,358)(3,160)
New shares issued— 1,147 
Payroll taxes paid in exchange for shares withheld(2,541)(2,140)
Shares repurchased(9,149)— 
Payments on revolving loan(10,000)(23,400)
Proceeds from revolving loan borrowings45,000 — 
Net cash provided by (used in) financing activities19,952 (27,553)
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS1,734 (516)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD7,153 7,566 
CASH AND CASH EQUIVALENTS, END OF PERIOD$8,887 $7,050 
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Cash paid for interest$1,347 $1,221 
Noncash investing activities - capital expenditures in accounts payable$1,015 $4,771 



HAWKINS, INC.
REPORTABLE SEGMENTS (UNAUDITED)
(In thousands)

Water
Treatment		IndustrialHealth and NutritionTotal
Three months ended June 30, 2024:
Sales$117,176 $103,202 $35,501 $255,879 
Gross profit34,955 21,876 7,824 64,655 
Selling, general, and administrative expenses14,166 6,639 4,059 24,864 
Operating income20,789 15,237 3,765 39,791 
Three months ended July 2, 2023:
Sales$93,651 $120,873 $36,596 $251,120 
Gross profit26,408 19,306 6,277 51,991 
Selling, general, and administrative expenses9,126 6,575 3,803 19,504 
Operating income 17,282 12,731 2,474 32,487 


Forward-Looking Statements. Various remarks in this press release constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include those relating to consumer demand for products containing our ingredients and the impacts of those demands, expectations for results in our business segments and the timing of our filings with the Securities and Exchange Commission. These statements are not historical facts, but rather are based on our current expectations, estimates and projections, and our beliefs and assumptions. Forward-looking statements may be identified by terms, including “anticipate,” “believe,” “can,” “could,” “expect,” “intend,” “may,” “predict,” “should,” or “will” or the negative of these terms or other comparable terms. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and other factors, some of which are beyond our control and are difficult to predict. Actual results may vary materially from those contained in forward looking statements based on a number of factors, including, but not limited to, changes in competition and price pressures, changes in demand and customer requirements or processes for our products, availability of product and disruptions to supplies, interruptions in production resulting from hazards, transportation limitations or other extraordinary events outside our control that may negatively impact our business or the supply chains in which we participate, changes in imported products and tariff levels, the availability of products and the prices at which they are available, the acceptance of new products by our customers and the timing of any such acceptance, and changes in product supplies. Additional information concerning potential factors that could affect future financial results is included in our Annual Report on Form 10-K for the fiscal year ended March 31, 2024, as updated from time to time in amendments and subsequent reports filed with the SEC. Investors should take such risks into account when making investment decisions. Shareholders and other readers are cautioned not to place undue reliance on forward-looking statements, which reflect our management’s view only as of the date hereof. We do not undertake any obligation to update any forward-looking statements.

Contacts:    Jeffrey P. Oldenkamp
Executive Vice President and Chief Financial Officer
612/331-6910
ir@HawkinsInc.com


v3.24.2
Cover
Jul. 31, 2024
Cover [Abstract]  
Document Type 8-K
Document Period End Date Jul. 31, 2024
Entity Registrant Name Hawkins, Inc.
Entity Incorporation, State or Country Code MN
Entity File Number 0-7647
Entity Tax Identification Number 41-0771293
Entity Address, Address Line One 2381 Rosegate,
Entity Address, City or Town Roseville,
Entity Address, State or Province MN
Entity Address, Postal Zip Code 55113
City Area Code 612
Local Phone Number 331-6910
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $.01 per share
Trading Symbol HWKN
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Entity Central Index Key 0000046250
Amendment Flag false
Grafico Azioni Hawkins (NASDAQ:HWKN)
Storico
Da Ott 2024 a Nov 2024 Clicca qui per i Grafici di Hawkins
Grafico Azioni Hawkins (NASDAQ:HWKN)
Storico
Da Nov 2023 a Nov 2024 Clicca qui per i Grafici di Hawkins